CAS 33025-33-1

1-Propanone, 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenyl-1-pyrrolidinyl)-, hydrochloride (1:1)

Description:

1-Propanone, 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenyl-1-pyrrolidinyl)-, hydrochloride (1:1), with CAS number 33025-33-1, is a chemical compound characterized by its complex structure, which includes a propanone moiety and a benzodioxin ring fused with a pyrrolidine group. This compound typically appears as a white to off-white crystalline solid and is soluble in polar solvents, reflecting its functional groups. The presence of the hydrochloride indicates that it is a salt form, which often enhances its stability and solubility in aqueous solutions. Its molecular structure suggests potential applications in medicinal chemistry, particularly in the development of pharmaceuticals, due to the presence of the pyrrolidine and phenyl groups, which can influence biological activity. As with many organic compounds, it is essential to handle this substance with care, following appropriate safety protocols, as it may exhibit specific toxicological properties or require special storage conditions.

Formula: C₂₁H₂₃NO₃·ClH

InChI: InChI=1S/C21H23NO3.ClH/c23-19(17-6-7-20-21(14-17)25-13-12-24-20)9-11-22-10-8-18(15-22)16-4-2-1-3-5-16;/h1-7,14,18H,8-13,15H2;1H

InChI key: InChIKey=QQZPGRDQMBPRFY-UHFFFAOYSA-N

SMILES: C(CC(=O)C=1C=C2C(=CC1)OCCO2)N3CC(CC3)C4=CC=CC=C4.Cl

Synonyms:

• 1,4-Benzodioxin, 1-propanone deriv.
• 1-Propanone, 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenyl-1-pyrrolidinyl)-, hydrochloride
• 1-Propanone, 1-(2,3-dihydro-1,4-benzodioxin-6-yl)-3-(3-phenyl-1-pyrrolidinyl)-, hydrochloride (1:1)
• 33025-33-1
• Piroxan
• Proroxan hydrochloride
• Pyrroxan
• Pyrroxan hydrochloride

1-(2,3-Dihydro-1,4-benzodioxin-6-yl)-3-(3-phenylpyrrolidin-1-yl)propan-1-one HCl

CAS: 33025-33-1

Naltrexone is a drug that is used in the treatment of addiction to opioids and alcohol. It has been shown to inhibit the breakdown of endorphins, which leads to reduced pain sensitivity. Naltrexone also has anti-inflammatory properties, which may be due to its inhibition of prostaglandin synthesis. Naltrexone binds to opioid receptors and blocks their action, preventing the transmission of signals by the neurotransmitter dopamine. This binding prevents the euphoric effects associated with opioid abuse while still allowing pain relief. The use of naltrexone in inflammatory bowel disease was first proposed in 1978 based on its ability to reduce colonic motility in animal models and its subsequent effect on gut function.

Formula: C₂₁H₂₃NO₃·HCl

Purity: Min. 95%

Color and Shape: White Powder

Molecular weight: 373.87 g/mol

Ref: 3D-FD130466